Bio-Rad Laboratories Total Assets 2006-2018 | BIO

Bio-Rad Laboratories total assets from 2006 to 2018. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Bio-Rad Laboratories total assets for the quarter ending December 31, 2018 were $6.719B, a 60.51% increase year-over-year.
  • Bio-Rad Laboratories total assets for 2017 were $4.273B, a 10.97% increase from 2016.
  • Bio-Rad Laboratories total assets for 2016 were $3.851B, a 3.8% increase from 2015.
  • Bio-Rad Laboratories total assets for 2015 were $3.71B, a 11.03% increase from 2014.
Bio-Rad Laboratories Annual Total Assets
(Millions of US $)
2017 $4,273
2016 $3,851
2015 $3,710
2014 $3,341
2013 $3,389
2012 $3,444
2011 $3,097
2010 $3,063
2009 $2,536
2008 $2,037
2007 $1,972
2006 $1,596
2005 $1,427
Bio-Rad Laboratories Quarterly Total Assets
(Millions of US $)
Q3 2018 $6,719
Q2 2018 $6,386
Q1 2018 $6,215
Q4 2017 $4,273
Q3 2017 $4,186
Q2 2017 $4,143
Q1 2017 $3,953
Q4 2016 $3,851
Q3 2016 $4,020
Q2 2016 $3,875
Q1 2016 $3,753
Q4 2015 $3,710
Q3 2015 $3,666
Q2 2015 $3,525
Q1 2015 $3,326
Q4 2014 $3,341
Q3 2014 $3,386
Q2 2014 $3,468
Q1 2014 $3,441
Q4 2013 $3,389
Q3 2013 $3,280
Q2 2013 $3,483
Q1 2013 $3,457
Q4 2012 $3,444
Q3 2012 $3,303
Q2 2012 $3,169
Q1 2012 $3,188
Q4 2011 $3,097
Q3 2011 $2,970
Q2 2011 $3,044
Q1 2011 $2,909
Q4 2010 $3,063
Q3 2010 $2,682
Q2 2010 $2,527
Q1 2010 $2,547
Q4 2009 $2,536
Q3 2009 $2,478
Q2 2009 $2,344
Q1 2009 $1,955
Q4 2008 $2,037
Q3 2008 $2,015
Q2 2008 $2,099
Q1 2008 $2,053
Q4 2007 $1,972
Q3 2007 $1,712
Q2 2007 $1,655
Q1 2007 $1,607
Q4 2006 $1,596
Q3 2006 $1,524
Q2 2006 $1,494
Q1 2006 $1,415
Q4 2005 $1,427
Q3 2005 $1,426
Q2 2005 $1,393
Q1 2005 $1,399
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $9.156B $2.290B
Bio-Rad Laboratories, Inc., together with its subsidiaries, engages in the manufacture and supply of products and systems for the life science research, healthcare, analytical chemistry, and other markets worldwide. The company's products are used to separate complex chemical and biological materials, and to identify, analyze, and purify their components. It operates in two segments, Life Science and Clinical Diagnostics. The Life Science segment offers electrophoresis, image analysis, molecular detection, chromatography, gene transfer, sample preparation, and amplification products and services. The Clinical Diagnostics segment provides control, autoimmune, diabetes, and blood virus testing products. Bio-Rad is renowned worldwide among hospitals, universities, major research institutions, as well as biotechnology and pharmaceutical companies for its commitment to quality and customer service. The company is headquartered in Hercules, California.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $136.952B 27.07
Medtronic (MDT) Ireland $121.227B 17.72
Stryker (SYK) United States $72.547B 26.60
Boston Scientific (BSX) United States $51.696B 25.20
Baxter (BAX) United States $39.588B 25.33
Zimmer Biomet Holdings (ZBH) United States $25.898B 16.58
Smith & Nephew SNATS (SNN) United Kingdom $17.446B 0.00
Canopy Growth (CGC) Canada $14.852B 0.00
ResMed (RMD) United States $14.350B 27.21
Aurora Cannabis (ACB) Canada $9.141B 64.50
Hill-Rom Holdings (HRC) United States $6.962B 21.53
Perrigo (PRGO) Ireland $6.420B 10.41
Insulet (PODD) United States $5.800B 1956.80
GW Pharmaceuticals (GWPH) United Kingdom $5.092B 0.00
ICU Medical (ICUI) United States $4.698B 29.24
Haemonetics (HAE) United States $4.311B 38.24
Hutchison China MediTech (HCM) China $3.810B 0.00
Agios Pharmaceuticals (AGIO) United States $3.637B 0.00
Neogen (NEOG) United States $3.108B 47.74
NuVasive (NUVA) United States $2.892B 25.23
Quidel (QDEL) United States $2.514B 22.68
Aphria (APHA) $2.385B 105.89
National Vision Holdings (EYE) United States $2.274B 44.72
Cardiovascular Systems (CSII) United States $1.346B 966.50
Phibro Animal Health (PAHC) United States $1.283B 18.45
VAREX IMAGING (VREX) United States $1.275B 24.96
AtriCure (ATRC) United States $1.081B 0.00
MacroGenics (MGNX) United States $0.926B 0.00
Lantheus Holdings (LNTH) United States $0.911B 24.60
Cerus (CERS) United States $0.844B 0.00
PetIQ (PETQ) United States $0.831B 23.77
Omeros (OMER) United States $0.828B 0.00
NanoString Technologies (NSTG) United States $0.729B 0.00
Meridian Bioscience (VIVO) United States $0.715B 21.30
OraSure Technologies (OSUR) United States $0.664B 29.11
Eagle Pharmaceuticals (EGRX) United States $0.657B 22.35
Evolus (EOLS) United States $0.655B 0.00
TG Therapeutics (TGTX) United States $0.601B 0.00
LeMaitre Vascular (LMAT) United States $0.596B 28.35
Surmodics (SRDX) United States $0.563B 81.90
Quanterix (QTRX) United States $0.518B 0.00
BioLife Solutions (BLFS) United States $0.364B 150.23
Vapotherm (VAPO) United States $0.335B 0.00
Rockwell Medical (RMTI) United States $0.331B 0.00
Insys Therapeutics (INSY) United States $0.328B 0.00
Utah Medical Products (UTMD) United States $0.300B 19.49
Owens & Minor (OMI) United States $0.271B 3.76
Bovie Medical (APYX) United States $0.260B 0.00
Cytosorbents (CTSO) United States $0.241B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.238B 0.00
Zynex (ZYXI) United States $0.145B 15.52
Fonar (FONR) United States $0.137B 7.33
Surface Oncology (SURF) United States $0.116B 0.00
Chimerix (CMRX) United States $0.102B 0.00
Female Health (VERU) United States $0.100B 0.00
Chembio Diagnostics (CEMI) United States $0.096B 0.00
United-Guardian (UG) United States $0.087B 19.84
CAS Medical Systems (CASM) United States $0.072B 0.00
Neurotrope (NTRP) United States $0.065B 0.00
Trinity Biotech (TRIB) Ireland $0.058B 17.14
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.039B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Valeritas Holdings (VLRX) United States $0.035B 0.00
Senestech (SNES) United States $0.029B 0.00
Capricor Therapeutics (CAPR) United States $0.018B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.016B 0.00
Akers Biosciences Inc (AKER) United States $0.013B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
NeuroMetrix (NURO) United States $0.008B 15.29